14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.34 $4.99 Wednesday, 1st May 2024 SMMT stock ended at $4.70. This is 19.59% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 27.95% from a day low at $3.90 to a day high of $4.99.
90 days $3.26 $5.22
52 weeks $1.50 $5.22

Historical Summit Therapeutics plc prices

Date Open High Low Close Volume
May 01, 2024 $3.92 $4.99 $3.90 $4.70 5 361 745
Apr 30, 2024 $3.88 $4.06 $3.85 $3.93 1 689 783
Apr 29, 2024 $3.88 $4.06 $3.86 $3.88 1 420 572
Apr 26, 2024 $3.63 $3.90 $3.52 $3.86 1 377 163
Apr 25, 2024 $3.52 $3.62 $3.44 $3.55 1 366 145
Apr 24, 2024 $3.74 $3.80 $3.56 $3.59 1 254 355
Apr 23, 2024 $3.48 $3.92 $3.48 $3.73 1 754 665
Apr 22, 2024 $3.50 $3.56 $3.40 $3.49 1 237 585
Apr 19, 2024 $3.50 $3.55 $3.34 $3.50 1 594 143
Apr 18, 2024 $3.61 $3.66 $3.50 $3.51 1 203 754
Apr 17, 2024 $3.57 $3.63 $3.47 $3.57 1 371 598
Apr 16, 2024 $3.61 $3.61 $3.49 $3.54 1 222 012
Apr 15, 2024 $3.69 $3.80 $3.62 $3.66 887 135
Apr 12, 2024 $4.01 $4.06 $3.63 $3.67 1 310 417
Apr 11, 2024 $4.04 $4.18 $3.94 $4.03 1 291 856
Apr 10, 2024 $3.92 $4.12 $3.90 $4.00 1 824 680
Apr 09, 2024 $3.94 $4.18 $3.94 $4.08 1 691 542
Apr 08, 2024 $3.90 $4.06 $3.81 $3.95 1 585 344
Apr 05, 2024 $3.51 $3.88 $3.45 $3.88 2 421 357
Apr 04, 2024 $3.82 $3.93 $3.48 $3.54 2 321 407
Apr 03, 2024 $3.81 $4.00 $3.81 $3.95 1 713 455
Apr 02, 2024 $3.94 $4.07 $3.83 $3.85 1 495 295
Apr 01, 2024 $4.21 $4.24 $3.88 $3.98 1 823 763
Mar 28, 2024 $4.20 $4.64 $4.10 $4.14 4 606 262
Mar 27, 2024 $3.83 $3.89 $3.65 $3.75 1 417 503
Click to get the best stock tips daily for free!

About Summit Therapeutics plc

Summit Therapeutics plc Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, fo... SMMT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT